These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19096734)

  • 1. HAART and Liver: a discussion of hepatic disease in those living with HIV. Interview by Paul C Adams.
    Cooper C
    Can J Gastroenterol; 2008 Dec; 22(12):973-5. PubMed ID: 19096734
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights of the third international workshop on HIV and hepatitis coinfection.
    Vogel M; Rockstroh J
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):769-71. PubMed ID: 17914911
    [No Abstract]   [Full Text] [Related]  

  • 3. Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia.
    Toyoda H; Honda T; Katano Y; Goto H; Takamatsu J
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):645-6. PubMed ID: 16200339
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
    Lincoln D; Petoumenos K; Dore GJ;
    HIV Med; 2003 Jul; 4(3):241-9. PubMed ID: 12859323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapies for HIV and viral hepatitis coinfection.
    Cooper CL
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):81-9. PubMed ID: 15757459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
    Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
    Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus].
    Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el Estudio del Hígado (AEEH)
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):31.e1-31. PubMed ID: 20116629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
    Björkman P; Flamholc L; Molnegren V; Marshall A; Güner N; Widell A
    AIDS; 2007 Jul; 21(12):1641-3. PubMed ID: 17630561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
    Pineda JA; García-García JA; Aguilar-Guisado M; Ríos-Villegas MJ; Ruiz-Morales J; Rivero A; del Valle J; Luque R; Rodríguez-Baño J; González-Serrano M; Camacho A; Macías J; Grilo I; Gómez-Mateos JM;
    Hepatology; 2007 Sep; 46(3):622-30. PubMed ID: 17659577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Macías J; Pineda JA; Lozano F; Corzo JE; Ramos A; León E; García-García JA; Fernández-Rivera J; Mira JA; Gómez-Mateos J
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):675-80. PubMed ID: 14574616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.
    Abrescia N; D'Abbraccio M; Figoni M; Busto A; Butrico E; De Marco M; Viglietti R
    J Antimicrob Chemother; 2002 Nov; 50(5):763-5. PubMed ID: 12407142
    [No Abstract]   [Full Text] [Related]  

  • 17. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).
    Gazzard B;
    HIV Med; 2005 Jul; 6 Suppl 2():1-61. PubMed ID: 16011536
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human immunodeficiency virus infection and viral hepatitis].
    Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.